Trial Profile
Subjective assessment of brexpiprazole with acute schizophrenia: An open-label study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2019
Price :
$35
*
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 02 Feb 2019 Status changed from recruiting to discontinued.
- 13 Aug 2018 New trial record